Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8OQ7

CryoEM structure of human rho1 GABAA receptor in complex with inhibitor TPMPA

Summary for 8OQ7
Entry DOI10.2210/pdb8oq7/pdb
EMDB information17107
DescriptorGamma-aminobutyric acid receptor subunit rho-1, methyl(1,2,3,6-tetrahydropyridin-4-yl)phosphinic acid, 2-acetamido-2-deoxy-beta-D-glucopyranose, ... (9 entities in total)
Functional Keywordsgabaa receptor, rho1, membrane protein
Biological sourceHomo sapiens (human)
Total number of polymer chains5
Total formula weight287829.77
Authors
Chen, F.,Victor, T.,John, C.,Rebecca, J.H.,Lindahl, E. (deposition date: 2023-04-11, release date: 2023-08-30, Last modification date: 2024-10-16)
Primary citationCowgill, J.,Fan, C.,Haloi, N.,Tobiasson, V.,Zhuang, Y.,Howard, R.J.,Lindahl, E.
Structure and dynamics of differential ligand binding in the human rho-type GABA A receptor.
Neuron, 111:3450-, 2023
Cited by
PubMed Abstract: The neurotransmitter γ-aminobutyric acid (GABA) drives critical inhibitory processes in and beyond the nervous system, partly via ionotropic type-A receptors (GABARs). Pharmacological properties of ρ-type GABARs are particularly distinctive, yet the structural basis for their specialization remains unclear. Here, we present cryo-EM structures of a lipid-embedded human ρ1 GABAR, including a partial intracellular domain, under apo, inhibited, and desensitized conditions. An apparent resting state, determined first in the absence of modulators, was recapitulated with the specific inhibitor (1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid and blocker picrotoxin and provided a rationale for bicuculline insensitivity. Comparative structures, mutant recordings, and molecular simulations with and without GABA further explained the sensitized but slower activation of ρ1 relative to canonical subtypes. Combining GABA with picrotoxin also captured an apparent uncoupled intermediate state. This work reveals structural mechanisms of gating and modulation with applications to ρ-specific pharmaceutical design and to our biophysical understanding of ligand-gated ion channels.
PubMed: 37659407
DOI: 10.1016/j.neuron.2023.08.006
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (2.2 Å)
Structure validation

229183

PDB entries from 2024-12-18

PDB statisticsPDBj update infoContact PDBjnumon